News

New blood test for Alzheimer's approved by FDA
The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...
MedPage Today on MSN9h
FDA Approves Auto-Injector for Migraine, Cluster Headache
The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...
US FDA approves Amneal's self-administered migraine treatment
The U.S. Food and Drug Administration has approved Amneal Pharmaceuticals' self-administered migraine drug, giving way to a ...
FDA approves blood test that can help diagnose Alzheimer’s disease
The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other ...
The Times of India on MSN16m
FDA greenlights first-of-its-kind blood test for Alzheimer’s disease: How does it work?
The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test, the first blood test for early Alzheimer's ...
dvm3604h
FDA approves gene-editing technology for swine
The FDA recently approved a gene-editing technology used to make swine resistant to porcine reproductive and respiratory ...
First blood test for Alzheimer’s diagnosis cleared by FDA
The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...
STAT5h
FDA clears first blood test for diagnosing Alzheimer’s
The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...
Managed Healthcare Executive7h
FDA Approves First Advanced Anal Cancer Drug as First-Line Treatment
FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.
Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis
"We are pleased to receive the FDA's approval of LED BLU-U and look forward to seeing the positive impact this next ...
The American Journal of Managed Care10h
Retifanlimab Becomes First FDA-Approved Frontline Treatment for Advanced Anal Cancer
The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...
PharmExec10h
FDA Approves Incyte’s Zynyz as First-Line and Second-Line Treatment for Advanced Anal Cancer
Zynyz is the first and only FDA-approved first-line treatment for adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal.